Why Twist Bioscience Corporation (TWST) stock moved
Twist Bioscience Corporation (TWST) shares climbed 8.0% to $124.88 as of August 11, 2026, a significant gain from the prior close of $115.67. BestStocks flagged the session as a major change for TWST. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for TWST, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
TWST climbed 8.0% to $124.88
Twist Bioscience closed at $101.06 on August 3, 2026, up 10.4% from Friday's $91.55 — but the path there was extraordinary. The stock opened at $81.60, roughly 11% below the prior close, fell to an intraday low of $80.59, and then climbed for the rest of the session to finish about 25% above that low. The company had reported fiscal third-quarter 2026 results with record revenue of $118.4 million, up 23% year over year and ahead of a roughly $114.6 million consensus, alongside an adjusted (non-GAAP) diluted loss per share of $0.56. It also raised full-year fiscal 2026 revenue guidance to $456–$457 million from $442–$447 million and guided fiscal Q4 revenue to $123–$124 million against a roughly $117.4 million consensus.
What it means for Twist Bioscience Corporation investors
For Twist Bioscience Corporation investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Strong 8.0% price move; Twist Bioscience Corporation (TWST) moved +10.34% from $113.18 to $124.88 on 2026-08-10. Weighing against that: Earnings missed expectations; TWST moved -2.95% from its $112.40 open to a $109.08 close on 2026-08-06. Wall Street's consensus price target sits at $104.67, implying -16.2% downside from $124.88. Over the past 90 days analysts logged 0 upgrades and 1 downgrade. BestStocks rates the overall signal quality medium (62/100). With earnings roughly 94 days out, the next report is the most likely near-term test of the move.
TWST price reaction
TWST last traded at $124.88, up $9.21 (+7.96%) from the previous close of $115.67. The session traded on 1.5× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $85.47 and $124.88, and it currently sits about 100% of the way up that band.
Bullish and bearish analyst opinions on Twist Bioscience Corporation (TWST)
The consensus analyst price target on Twist Bioscience Corporation (TWST) is $104.67, 16.2% below the recent $124.88. Over the past 90 days analysts logged 0 upgrades, 7 maintains, and 1 downgrade. Here is how the bullish and bearish cases on TWST line up.
The bullish case
- Strong 8.0% price move.
- Twist Bioscience Corporation (TWST) moved +10.34% from $113.18 to $124.88 on 2026-08-10.
The bearish case
- The consensus analyst price target of $104.67 sits 16.2% below the recent $124.88, so the average target sees limited room to run.
- The most bearish analyst target is $89.00 (-28.7%).
- 1 analyst downgrade in the past 90 days, most recently Evercore ISI Group to In Line (2026-07-06).
- Earnings missed expectations.
- TWST moved -2.95% from its $112.40 open to a $109.08 close on 2026-08-06.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Aug 10, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for TWST
In-depth TWST event analyses
Frequently asked questions about TWST
Why did Twist Bioscience Corporation (TWST) stock move?
Twist Bioscience closed at $101.06 on August 3, 2026, up 10.4% from Friday's $91.55 — but the path there was extraordinary. The stock opened at $81.60, roughly 11% below the prior close, fell to an intraday low of $80.59, and then climbed for the rest of the session to finish about 25% above that low. The company had reported fiscal third-quarter 2026 results with record revenue of $118.4 million, up 23% year over year and ahead of a roughly $114.6 million consensus, alongside an adjusted (non-GAAP) diluted loss per share of $0.56. It also raised full-year fiscal 2026 revenue guidance to $456–$457 million from $442–$447 million and guided fiscal Q4 revenue to $123–$124 million against a roughly $117.4 million consensus.
How much did TWST stock rise?
TWST gained 7.96% ($9.21) versus the prior close of $115.67, last trading at $124.88 on 1.5× average volume.
When is Twist Bioscience Corporation's next earnings date?
TWST's next earnings report is estimated for 2026-11-13 — about 94 days away.
What is the analyst price target for TWST?
The consensus analyst price target for TWST is $104.67, about 16.2% below the current $124.88. Over the past 90 days, analysts recorded 0 upgrades, 7 maintains, and 1 downgrade.
How BestStocks tracks TWST
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared TWST-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for TWST, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of August 11, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.